Skip to main content

Table 2 Comparison of choroidal thickness between patients with neovascular age-related macular degeneration and age-matched controls

From: Peripapillary choroidal thickness after intravitreal ranibizumab injections in eyes with neovascular age-related macular degeneration

 

AMD group

Control group

P value*

(n = 39)

(n = 39)

Subfoveal CT (μm)

228.6 ± 78.6

224.2 ± 54.7

0.775

Peripapillary CT (μm)

 Mean

153.2 ± 45.3

148.2 ± 38.8

0.600

 Superior

165.2 ± 49.5

160.3 ± 42.6

0.637

 Nasal

153.2 ± 43.0

148.3 ± 36.5

0.591

 Inferior

127.3 ± 40.0

122.7 ± 32.5

0.577

 Temporal

167.1 ± 54.5

161.4 ± 49.8

0.635

  1. Continuous variables are expressed as mean ± standard deviation
  2. *Comparison of baseline parameters between the control group and AMD group, P value was based on the student t-test
  3. AMD age-related macular degeneration, CT choroidal thickness
Back to article page

BMC Ophthalmology

ISSN: 1471-2415

Contact us